Effects of electrical stimulation of the hippocampus (HPC), lateral amygdala (1-AMYG) and midbrain central gray matter (CG) on the release of ovulatory gonadotropin were examined using proestrous Wistar rats with or without pretreatment with reserpine, atropine or p-chlorophenylalanine (PCPA) at such dosage that had been confirmed not to block ovulation.
Effects of electrical stimulation of the hippocampus (HPC), lateral amygdala (1-AMYG) and midbrain central gray matter (CG) on the release of ovulatory gonadotropin were examined using proestrous Wistar rats with or without pretreatment with reserpine, atropine or p-chlorophenylalanine (PCPA) at such dosage that had been confirmed not to block ovulation.
Electrical stimulation of the HPC, 1-AMYG or CG under light ether anesthesia just before the critical period prevented a rise in serum LH, FSH and prolactin levels at 18:00. Pretreatment with atropine (200mg/kg body wt, sc) was effective to abolish this inhibitory effect of the HPC stimulation on the release of LH and FSH, whereas reserpine treatment (1mg/kg body wt, ip) did not affect the effect. The inhibitory effect of the 1-AMYG or CG stimulation on LH and FSH release was abolished by treatment with PCPA (150 mg/kg body wt, ip), while neither atropine nor reserpine had any effect. The inhibitory effect of the HPC stimulation on the release of these hormones was also blocked by PCPA treatment.
In regard to the prolactin release, it was inhibited by the stimulation of the HPC, 1-AMYG or CG in both the non-treated rat and in the atropine or PCPA-treated one, while in the reserpine-treated rat it was not inhibited but rather was facilitated by these stimulations.
It was assumed that the normal maintenance of both cholinergic and serotonergic neural links for the expression of the HPC inhibition on ovulatory LH, FSH and prolactin secretion and that of serotonergic link for the expression of the 1-AMYG or CG inhibition are needed. The inhibitory action on prolactin release changed into facilitation under the depletion of monoamines, but the mechanism is unknown.
It is apparent from the recent studies, that the forebrain limbic structure plays an important role in modulating the secretion of gonadotropins.
Evidence has been presented that the hippocampus Kawakami, 1968, Velasco and Taleisnik, 1969; 1973) and the lateral part of amygdala (Kawakami and Kimura, 1975a) exert an inhibitory influence on the release of gonadotropin. Carrer and Taleisnik (1970) have shown that the electrochemical stimulation of some areas in the midbrain structures, the ventral tegmental area, the raphe nuclei and the central gray matter also influence the gonadotropin release in an inhibitory manner.
On the other hand, a large number of investigations have demonstrated an involvement of biogenic amines in the CNS regulation of gonadotropin secretion (see Reviews; Hokfelt and Fuxe, 1972; McCann et al., 1972; Coppola, 1971) . The substances most generally accepted to serve as neurotransmitters somewhere in the brain include et al.
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Most of information seems to support the concept that the catecholaminergic (see Review; Sawyer, 1975) and cholinergic Sawyer et al., 1949; Libertun and McCann, 1973; Kamberi, 1973) systems have a facilitatory effect, whereas the indolaminergic (Labhsetwar, 1971; Kamberi et al., 1971; Schneider and McCann, 1970; Wilson and McDonald, 1974) system has an inhibitory effect on the release of LRF, FRF and PIF from the hypothalamus.
The present study was performed to know the mode of involvement of these biogenic amines in the expression of inhibitory action of limbic forebrain structure. The experiment investigated the influence of reserpine, atropine, and p-chlorophenylalanine on the inhibitory effects of electrical stimulation of the hippocampus, lateral amygdala and central gray matter on ovulatory gonadotropin release.
Materials and Methods
Adult female rats of Wistar strain, weighing 200-250 g, were used in this study. All rats were caged in a light controlled room (lights on from 5:00 to 19:00) and supplied with food and water ad lib. Daily vaginal smears were taken in the morning and only rats in proestrus, which had shown at least 2 consecutive 4-day cycles, were employed.
In order to determine the dosage of each drug to be investigated, at which spontaneous ovulation is not blocked even when it was administered on the day of proestrus, atropine sulfate (Wako Purechemical Ind.) dissolved in 0.9% saline was injected sc at the dosage of 200, 700mg/kg body wt between 10:30-11:00, and reserpine (Apoplon, Daiichi Seiyaku, 1.0mg/ml ampoules) or p-chlorophenylalanine (PCPA, Tokyo Kasei Kogyo), the latter being suspended in 0.9% saline, was injected ip at the dosage of 1, 2.5mg/kg body wt or 150mg/kg body wt at 11:00, respectively. The occurrence of ovulation was checked next morning.
As shown in Table 1 and cited in the result again, injection of reserpine at the dosage of 1 mg/kg body wt, atropine 200mg/kg body wt and PCPA 150mg/kg body wt permitted a high percentage of animals to ovulate.
The following experiment was performed employing these dosages of drugs. In agreement with previous reports , the relatively large dosage of atropine (700 mg/kg body wt) blocked ovulation, when it was administered about noon on the day of proestrus. Lower dosage (200mg/kg body wt), however, interefered with ovulation only in 2 out of 6 animals tested ( Table 1) . As seen Figs. 1, 2 and 3, the increases of serum LH, FSH and prolactin levels in the atropine (200mg/kg body wt)-treated and shamstimulated animals at 18:00 compared with those levels in the control animal at 12:00 were significant. Serum LH, FSH and prolactin concentrations at 18:00 in the rat stimulated in the 1-AMYG or CG were significantly low (p< 0.05 vs the sham-stimulated control), whereas in the rat stimulated in the HPC these concentrations showed no significant differences.
The blocking effect of the HPC stimulation on ovulation was restrained by pretreatment with atropine at the dosage of 200mg/kg body wt, since a high percentage of the rat stimulated in the HPC ovulated (80% vs 56% in the rat with no treatment). By contrast, in the rats stimulated in the 1-AMYG with atropine pretreatment ovulation was blocked (Table 2) . Reserpine:
In the rat which received ip injection of reserpine at the dosage of 5mg/kg or 2mg/kg body wt between 11:00 and 11:30 on the day of proestrus, ovulation did not occur in 3 out of 4, and in 3 out of 5 animals, respectively ( sham-stimulated animals (Fig. 3) . 1-AMYG was effective in preventing spontaneous ovulation even in the rat treated with reserpine at a dosage of 1mg/kg (Table 2) . PCPA: In_jection of PCPA at the dosage of 150mg/kg at 11:00 on the day of proestrus exerted no influence on ovulation (Table 1) . There were no significant difference between the serum LH, FSH and prolactin levels in the non-treated control rat and those in the PCPA-treated sham-stimulated rat (Fig. 4) The results of the present study the electrical stimulation of the HPC, 1-AMYG or CG just before the critical period on the day of proestrus inhibits the ovulatory release of LH and FSH are in agreement with previous reports (Velasco and Taleisnik, 1969; Carrer and Taleisnik, 1970; Kawakami, et al., 1972; Kawakami and Kimura, 1975a selectively antagonizes acetylcholine at the site where acetylcholine has muscarinic action, and PCPA at a high dose depletes both serotonin and catecholamine contents in the brain (Miller et al., 1970) , whereas at a low dose it depletes selectively serotonin (Koe and Weissman, 1966) . It is assumed, therefore, that the normal maintenance of both cholinergic and serotonergic neural links It could not be clarified in the present experiment, however, whether these cholinergic and/or serotonergic neuronal links were required at the site of stimulation or for the transmission of impulses made by the stimulation to the LH-release neural elements. The significant amount of 5-hydroxytryptamine (5-HT) is found in the mammalian brain, and it has early been noted that the HPC contains a high concentration of serotonin, and that even the piriform cortex and AMYG contain more serotonin than the hypothalamus (Paasonen et al., 1957 observed, but 5-HT cell bodies have not (Fuxe, 1965a, b; Anden et al., 1966; Ungerstedt, 1971; Kuhar et al., 1972) . Those seem to indicate that the serotonin stored in those nervous system is profoundly related to the activity of the HPC and AMYG as well as the CG itself. In fact, axo-somatic serotonin-containing synapses on AMYG neurons whose 1967) and seizure discharges in the HPC EEG (Kaneko et al., 1975) (Shute and Lewis, 1966) , and thus, the HPC neuronal activity is highly affected by administration of acetylcholine, eserine or atropine (Salmoiraghi and Stefanis, 1966; Green et al., 1960) . It was reported as well that especially the lateral basal and basal posterior AMYG show intense acetycholinesterase activity (Jacobowitz and Palkovits, 1974) . However, the HPC and AMYG, both do not contain cells with such activity (Shute and Lewis, 1966) . Those findings also indicate that the cholinergic inputs influence the activity of the HPC and AMYG.
The possibility that cholinergic and/or serotonergic mechanisms are involved in the transmission of inhibitory influence from the stimulation sites cannot be excluded. This seems most apparent for the CG, which has direct serotonergic connections with the hypothalamus through the medial forebrain bundle (MFB; Dahlstrom and Fuxe, 1964 (1972) suggested two available pathways to the hypothalamus; one directly through the dorsal longitudinal fasciculus and the other via the MFB-hypocampus-corticohypothalamic tract, and when one is lesioned the stimulation effect reaches the hypothalamus through the other one. The fornical fibers, which themselves do not contain cholinesterase, project to the anterior limbic area, nucleus accumbens, nucleus of anterior commisure, whose cells are rich in cholinesterase (Lewis and Shute, 1967) , and cholinesterase activity is also high in the supraoptic nucleus, medial preoptic area, septal nucleus, and arcuate nucleus (Jacobowitz and Palkovits, 1974; Meszaros et al., 1969) , which has been proved to receive projections from the HPC (Raisman and Field, 1971; Heimer and Nauta, 1969; Nauta, 1956) . Since under the treatment with reserpine, at such dosage that is not enough to prevent ovulatory neural mechanism from operating, the HPC stimulation was also effective to inhibit ovulatory release of LH, it may be possible that the HPC impulses reach such cholinergic mechanism through the fornical, presumably, catecholaminergic fibers (Reivich and Glowinski, 1967) . Supporting this, the inhibition by the HPC stimulation on the firing rate of arcuate neurons was mimicked by iontophoretic application of acetylcholine (Kawakami and Sakuma, 1975) . If that were the case, the blockade of HPC inhibitory effect by atropine treatment would be due to blocking of this cholinergic transmission. The mechanism for transmission of the 1-AMYG inhibition is obscure, since neither atropine or reserpine prevented the action. The possibility is that the inhibition of 1-AMYG exerts an effect directly on the medial AMYG activity, which is a major ovulatory neural apparatus (Kawakami and Kimura, 1975b) , or reaches the hypothalamus through catecholaminergic pathway, namely the stria terminalis (Reivich and Glowinski, 1967; Kawakami and Kimura, 1975a) inspite of reserpine treatment; stimulation of the 1-AMYG was effective to inhibit electrical activity in the medial preoptic area and arcuate nucleus (Kawakami et al., 1974a) . It was reported that atropine interfered with ovulation when given before the critical period Sawyer et al., 1949) , and also inhibited the rise in plasma LH before ovulation or after castration (Libertun and McCann, 1973; Kamberi, 1973 of HPC inhibitory influence on the LH release. Libertun and McCann (1974) recently reported that the immediate effect of muscarinic drugs injected sc was a suppression in the release of both LH and prolactin , although a delayed one was the facilitation . In our related experiment, it was observed that injection of anticholinesterase on the day before proestrus blocked the expected ovulation (Kimura, unpublished) . Further studies are needed for determining the exact role of cholinergic mechanism in the control of gonadotropin release. In contrast, the majority of the experimental results shows that serotonin acts as an inhibitor of gonadotropin release. Subcutaneous or intraperitoneal injection of serotonin was found to inhibit spontaneous and PMSinduced ovulation in adult and immature rats, respectively (O'Steen, 1965; Endersby et al., 1970) , and intraventricular administration of 5-HT inhibited even basal secretion of LH and FSH (Kamberi, 1973 Schneider and McCann, 1970 (Kawakami et al., unpublished) , and that into the medial forebrain bundle inhibited the induced ovulation in immature rats (Wilson, 1974 (Clemens et al., 1971; Kawakami et al., 1974b and FSH but also that of prolactin (Kimura, Kawagoe and Kawakami, unpublished suckling in the lactating rat (Kordon et al., 1973/4; Caligaris and Taleisnik, 1974 
